Roth Capital Starts Sunesis Pharmaceuticals Inc. (SNSS) at Buy
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Rating Summary:
5 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
5 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Roth Capital initiates coverage on Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) with a Buy. PT $6.00.
For more ratings news on Sunesis Pharmaceuticals Inc. click here and for the rating history of Sunesis Pharmaceuticals Inc. click here.
Shares of Sunesis Pharmaceuticals Inc. closed at $1.35 yesterday.
For more ratings news on Sunesis Pharmaceuticals Inc. click here and for the rating history of Sunesis Pharmaceuticals Inc. click here.
Shares of Sunesis Pharmaceuticals Inc. closed at $1.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- BNP Paribas Exane Starts NIQ Global Intelligence Plc (NIQ) at Outperform
- H.C. Wainwright Starts ImageneBio (IMA) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
